Fisetin has been shown to suppress cell proliferation through G2/M-phase cell cycle arrest, the downregulation of cyclin D1, and the upregulation of p21/p27 in renal cell carcinoma (RCC). Here, CCND1 is linked to hereditary clear cell renal cell carcinoma.